Compositions and methods for acylating lactams

US10040784B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10040784-B2
Application numberUS-201715454198-A
CountryUS
Kind codeB2
Filing dateMar 9, 2017
Priority dateMar 11, 2016
Publication dateAug 7, 2018
Grant dateAug 7, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This disclosure provides methods for intermolecular enantioselective C-acylation of lactams with quaternary stereogenic centers by applying a chiral Ni catalyst. The methods comprise treating a lactam with a chiral Ni catalyst, an aryl nitrile, and an aryl halide.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for the preparation of a compound of formula (Ia): comprising treating a compound of formula (IIa): or a salt thereof; with a complex formed by contacting Ni(COD) 2 with a chiral ligand; an aryl nitrile; an aryl halide; and a base; wherein, as valence and stability permit, R 1 represents hydrogen or optionally substituted alkyl, cycloalkyl, (cycloalkyl)alkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, alkenyl, alkynyl, —C(O)alkyl, —C(O)aryl, —C(O)aralkyl, —C(O)heteroaryl, —C(O)heteroaralkyl, —C(O)O(alkyl), —C(O)O(aryl), —C(O)O(aralkyl), —C(O)O(heteroaryl), —C(O)O(heteroaralkyl), —S(O) 2 (aryl), —S(O) 2 (alkyl), —S(O) 2 (haloalkyl), —OR 10 , —SR′, or —NR 10 R 11 ; R 2 represents substituted or unsubstituted alkyl, alkenyl, alkynyl, aralkyl, aralkenyl, aryl, heteroaralkyl, heteroaralkenyl, heteroaryl, (cycloalkyl)alkyl, cycloalkyl, (heterocycloalkyl)alkyl, heterocycloalkyl, alkoxy, amino, or halo; R 3 represents substituted or unsubstituted aryl; B and D independently for each occurrence represent, as valence permits, O, S, NR 4 , CR 5 R 6 , C(O), CR 5 , or N; provided that no two adjacent occurrences of N, B and D are NR 4 , O, S, or N; E represents CR 5 R 6 , C(O) or CR 5 ; R 4 represents hydrogen or optionally substituted alkyl, cycloalkyl, (cycloalkyl)alkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, alkenyl, alkynyl, —C(O)alkyl, —C(O)aryl, —C(O)aralkyl, —C(O)heteroaryl, —C(O)heteroaralkyl, —C(O)O(alkyl), —C(O)O(aryl), —C(O)O(aralkyl), —C(O)O(heteroaryl), —C(O)O(heteroaralkyl), —S(O) 2 (aryl), —S(O) 2 (alkyl), —S(O) 2 (haloalkyl), OR 10 , —SR 10 , or —NR 10 R 11 ; R 5 and R 6 each independently represent hydrogen, hydroxyl, halogen, nitro, alkyl, cycloalkyl, (cycloalkyl)alkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, (heterocycloalkyl)alkyl, heterocycloalkyl, alkenyl, alkynyl, cyano, carboxyl, sulfate, amino, alkoxy, aryloxy, arylalkoxy, alkylamino, alkylthio, hydroxyalkyl, alkoxyalkyl, aminoalkyl, thioalkyl, haloalkyl, ether, thioether, ester, amido, thioester, carbonate, carbamate, urea, sulfonate, sulfone, sulfoxide, sulfonamide, acyl, acyloxy, or acylamino; or any two occurrences of R 1 , R 4 , R 5 , and R 6 on adjacent N, B, D, or E groups, taken together with the intervening atoms, form an optionally substituted aryl, heteroaryl, cycloalkyl, cycloalkenyl, heterocycloalkyl, or heterocycloalkenyl group; each occurrence of independently represents a double bond or a single bond as permitted by valence; m and n are integers each independently selected from 0, 1, and 2; and R 10 and R 11 are independently selected for each occurrence from hydrogen or substituted or unsubstituted alkyl, aralkyl, aryl, heteroaralkyl, heteroaryl, (cycloalkyl)alkyl, cycloalkyl, (heterocycloalkyl)alkyl, heterocycloalkyl, alkenyl, and alkynyl. 2. The method of claim 1 , wherein the sum of m and n is 0, 1, 2, or 3. 3. The method of claim 1 , wherein each occurrence of B, D, and E is independently —CR 5 R 6 —, or —CR 5 —, or —C(O)—. 4. The method of claim 1 , wherein E is —CR 5 R 6 —; and the sum of m and n is 0. 5. The method of claim 4 , wherein R 1 is selected from optionally substituted alkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, alkenyl, —C(O)alkyl, —C(O)aryl, —C(O)aralkyl, —C(O)heteroaryl, —C(O)heteroaralkyl, —C(O)O(alkyl), —C(O)O(aryl), —C(O)O(aralkyl), —C(O)O(heteroaryl), —C(O)O(heteroaralkyl), and —S(O) 2 (aryl); R 5 is selected from hydrogen, hydroxyl, halogen, alkyl, cycloalkyl, (cycloalkyl)alkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, (heterocycloalkyl)alkyl, heterocycloalkyl, alkenyl, alkynyl, amino, alkoxy, aryloxy, alkylamino, amido, and acylamino; or R 1 and the occurrence of R 5 on E are taken together to form an optionally substituted heteroaryl, heterocycloalkyl, or heterocycloalkenyl group. 6. The method of claim 1 , wherein the compound of formula (I) is represented by formula (Ib): and the compound of formula (II) is represented by formula (Ilb): 7. The method of claim 6 , wherein R 1 is selected from optionally substituted alkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, alkenyl, —C(O)alkyl, —C(O)aryl, —C(O)aralkyl, —C(O)heteroaryl, —C(O)heteroaralkyl, —C(O)O(alkyl), —C(O)O(aryl), —C(O)O(aralkyl), —C(O)O(heteroaryl), —C(O)O(heteroaralkyl), and —S(O) 2 (aryl); R 5 is selected from hydrogen, hydroxyl, halogen, alkyl, cycloalkyl, (cycloalkyl)alkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, (heterocycloalkyl)alkyl, heterocycloalkyl, alkenyl, alkynyl, amino, alkoxy, aryloxy, alkylamino, amido, and acylamino; or R 1 and R 5 on E are taken together to form an optionally substituted heteroaryl, heterocycloalkyl, or heterocycloalkenyl group. 8. The method of claim 1 , wherein R 2 represents substituted or unsubstituted alkyl, alkenyl, alkynyl, aralkyl, aralkenyl, aryl, heteroaralkyl, heteroaralkenyl, heteroaryl, (cycloalkyl)alkyl, cycloalkyl, (heterocycloalkyl)alkyl, heterocycloalkyl, or halo. 9. The method of claim 1 , wherein the complex is present in an amount from about 0.1 mol % to about 20 mol % relative to the compound of formula (II). 10. The method of claim 1 , wherein the chiral ligand is an enantioenriched phosphine ligand. 11. The method of claim 1 , wherein the chiral ligand is used in an amount from about 0.5 mol % to about 50 mol % relative to the compound of formula (IIa). 12. The method of claim 1 , wherein the aryl nitrile is an optionally substituted benzonitrile or a naphthonitrile. 13. The method of claim 1 , wherein the treating a compound of formula (IIa) further comprises treating with a lithium salt. 14. The method of claim 1 , wherein the treating a compound of formula (IIa) is in the presence of toluene, tetrahydrofuran, dioxane, methyl tert-butyl ether, dimethoxyethane, or a mixture of toluene and tetrahydrofuran. 15. The method of claim 1 , whereby the compound of formula (Ia) is enantioenriched. 16. The method of claim 1 , wherein: B, D, and E are each independently CR 5 R 6 , C(O), or CR 5 ; R 1 represents an optionally substituted cycloalkyl, (cycloalkyl)alkyl, aryl, aralkyl, heteroaryl, or heteroaralkyl; and R 2 represents substituted or unsubstituted alkyl, alkenyl, alkynyl, aralkyl, aralkenyl, aryl, heteroaralkyl, heteroaralkenyl, heteroaryl, (cycloalkyl)alkyl, cycloalkyl, (heterocycloalkyl)alkyl, or heterocycloalkyl. 17. The method of claim 1 , wherein: B, D, and E are each independently CR 5 R 6 , C(O), or CR 5 ; R 1 represents an optionally substituted cycloalkyl, (cycloalkyl)alkyl, aryl, or aralkyl; and R 2 represents substituted or unsubstituted alkyl, alkenyl, alkynyl, aralkyl, aralkenyl, aryl, (cycloalkyl)alkyl, or cycloalkyl. 18. The method of claim 6 , wherein: R 1 represents an optionally substituted cycloalkyl, (cycloalkyl)alkyl, aryl, aralkyl, heteroaryl, heteroaralkyl; R 2 represents substituted or unsubstituted alkyl, alkenyl, alkynyl, aralkyl, aralkenyl, aryl, heteroaralkyl, heteroaralkenyl, heteroaryl, (cycloalkyl)alkyl, cycloalkyl, (heterocycloalkyl)a

Assignees

Inventors

Classifications

  • C07D409/06Primary

    linked by a carbon chain containing only aliphatic carbon atoms · CPC title

  • with substituted hydrocarbon radicals directly attached to the ring nitrogen atom · CPC title

  • Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title

  • with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10040784B2 cover?
This disclosure provides methods for intermolecular enantioselective C-acylation of lactams with quaternary stereogenic centers by applying a chiral Ni catalyst. The methods comprise treating a lactam with a chiral Ni catalyst, an aryl nitrile, and an aryl halide.
Who is the assignee on this patent?
California Inst Of Techn
What technology area does this patent fall under?
Primary CPC classification C07D409/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).